Granules India (BOM:532482) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532482 Granules India Ltd BOM:532482
81 GF Score
Price ₹841.65
GF Value ₹637.97
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Granules India Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:532482
81GF Score
Granules India Ltd BOM:532482
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Granules India (BOM:532482) Overvalued in 2026?

Based on GuruFocus' analysis, Granules India stock appears to be overvalued. The current stock price of ₹841.65 is trading 31.9% above its estimated GF Value™ of ₹637.97. GuruFocus considers Granules India to be Significantly Overvalued.

Key valuation signals for BOM:532482:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹637.97 vs. price of ₹841.65 (31.9% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the BOM:532482 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Granules India Business Description

Other Exchanges GRANULES:India
Address Botanical Garden Road, 15th Floor, Granules Tower, Kondapur, Hyderabad, TG, IND, 500084
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
81GF Score

Get the complete analysis for BOM:532482

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹841.65
Price
₹637.97
GF Value